Replies to post #104043 on Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Is Biogen still in the picture for MS? It has been quite a while. Maybe they were waiting for the patent news to finalize a decision.

[McMagyar]

Bourbon IMO BP is and has been all over Anavex..

they are not watching..
they are trying to duplicate,
buying other Sigma 1 Co for Billions..

you are missing the storm brotrher..because YOU ARE IN IT'S EYE!

[BAR123]

Bourbon, we don't need a multibillion dollar bidding war right now as you state. What would be nice is what Allergan did for Heptares paying them 125 million upfront and another 665 million associated with successful phase 1-3 clinical development. Then a 2 1/2 billion dollar licensing agreement for the first three products to launch along with milestone payments along the way. That would certainly jump us up to about 30 bucks a share pretty quickly.

[stealthways]

Respect your opinion but IMO Pharma is too smart to sit and wait for further trial studies...
the evidence is there now .... even the collection of animal studies is reason enough ... read falconers discussion on murine studies (I think he has it accurate), and do not believe the downplaying about "just mice studies" , pharma knows you do not get that much confirming animal studies without the real deal and remember at a microscopic level the firing of the animal neuron is identical to a human neuron (Dr. V was a smart man) .... and that is just animal studies, in human the P300 alone (and never before) is like flashing current "DA" ya I think we have something here doc..... If CNS pharma is not all over this now behind the scenes I would be very surprised... The long community here know what here, we have, would pharma not...